Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-28

Clinical Trial Update: Tranexamic Acid : Nebulization vs IV Route for Hemoptysis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing nebulized tranexamic acid to intravenous tranexamic acid for hemoptysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Health Sciences Lahore | Conditions: Hemoptysis, NEBULIZATION | Phase 2, Phase 3 | Status: COMPLETED